GlobeNewswire

Elanders announces date of Quarterly Report January-September 2019 and Conference Call

Share

Elanders will issue its Quarterly Report for the third quarter 2019 on Monday October 21 at 13:00 CET, followed by a conference call at 15:00 CET, hosted by President and CEO Magnus Nilsson and CFO Andréas Wikner.

We invite fund managers, analysts and the media to participate in the conference call. Please see below details to join the conference.

To join this event, please use the below Click to Join link 5-10 minutes prior to start time, where you will be asked to enter your phone number and registration details. Our Event Conferencing system will call you on the phone number you provide and place you into the event. Please note that the Click To Join link will be active 15 minutes prior to the event.

CLICK TO JOIN

Use the Click to Join option above for the easiest way to join your conference or use one of the access numbers below:

Sweden: +46 (0)8 5033 6546
Germany: +49 (0)69 2222 10763
UK: +44 (0)330 336 9401
USA: +1 929-477-0338

Participant Passcode: 707987

Agenda
14:50 Conference number is opened
15:00 Presentation of quarterly results
15:20 Q&A
16:00 End of the conference

During the conference call a presentation will be held. To access the presentation, please use this link:

https://www.elanders.com/presentations

For further questions, please contact
Magnus Nilsson, President and CEO, telephone: +46 31 750 07 50
Andréas Wikner, CFO, telephone: +46 31 750 07 50

Attachment

About GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

Vaisala appoints Kai Öistämö as President and CEO3.6.2020 08:00:00 CESTPress release

Vaisala Corporation Inside information June 3, 2020 at 9:00 a.m. (EEST) Vaisala appoints Kai Öistämö as President and CEO Vaisala’s Board of Directors has appointed Kai Öistämö, b. 1964, as President and CEO. Öistämö starts at Vaisala latest on October 1, 2020. Vaisala’s current President and CEO Kjell Forsén is to step down from his current position and retire by the end of 2020. Kai Öistämö joins Vaisala from US technology company InterDigital, where he has held the position as Chief Operating Officer since 2018, before which he served as Member of the Board. Prior to InterDigital, Öistämö worked at private equity company Siris Capital Group and held several demanding leadership positions at Nokia, where he also was part of the company’s Executive Board 2006–2014. Öistämö holds a PhD degree in computer science from Tampere University of Technology. “I want to warmly welcome Kai Öistämö to Vaisala. Kai brings broad experience from the technology field, from research and development to

Hexagon Purus awarded contract by Toyota for hydrogen powered electric heavy-duty trucks – continuing the drive toward zero-emission commercial transport3.6.2020 07:15:54 CESTPress release

Hexagon Purus, a subsidiary of Hexagon Composites, has been awarded a contract to supply hydrogen systems to Toyota Motor North America (TMNA) for its newest prototype hydrogen-powered heavy-duty fuel cell electric truck powertrains. The total sales value of the order is approximately 1 million USD. This is the third heavy-duty truck project in three years that Hexagon Purus has collaborated on with Toyota. Earlier projects included Toyota’s proof of concept for the Los Angeles ports, supporting the ports’ efforts to reduce harmful emissions (2017), and a hydrogen Tobus model from CaetanoBus that utilizes Toyota’s leading fuel cell electric technology (2019). Driving energy transformation The world-leading OEM has expressed that they believe that hydrogen fuel cell electric technology has tremendous potential to become the powertrain of the future. Heavy-duty trucks are typically used for highway transportation; therefore, they are required to have sufficient cruising range and load ca

Media Release | MCH Group | Capital increase | Canton of Basel-Stadt3.6.2020 07:00:00 CESTPress release

Basel-Stadt specifies the key figures for its future stake in MCH Group Ltd. In the context of the General Meetings held on 29 January 2020 and 24 April 2020, MCH Group Ltd. announced that it was looking into a capital increase as a means of financing the investments required for the implementation of its corporate strategy. This would be accompanied by the corresponding changes in the shareholder structure, the shareholder rights set out in the Statutes and the composition of the Board of Directors. If the planned capital increase can go ahead, it will be achieved through the involvement of a new investor and the participation of the shareholders to date, who will be granted proportional subscription rights and be able to decide whether they wish to exercise these or not. In the case of the Canton of Basel-Stadt, which currently holds 33.5 % of the shares in MCH Group Ltd., it is the cantonal parliament that has to take the decision regarding the exercise of the subscription right. Th

Hoylu AB: Publicerar årsredovisning för 20192.6.2020 23:30:00 CESTPressemelding

Hoylu AB (publ) meddelar idag att årsredovisningen för räkenskapsåret 2019 finns tillgänglig på bolagets hemsida: https://www.hoylu.com/investor-relations/financial-reports/ För ytterligare information, vänligen kontakta: Stein Revelsby, VD på Hoylu + 1 213 440 2499 e-post: sr@hoylu.com Karl Wiersholm, CFO på Hoylu + 1 425 829 2316 e-post: kw@hoylu.com Om Hoylu Hoylus uppdrag är att göra distansarbete och informationsutbyte enkelt. Genom vår anpassningsbara Connected Workspaces™ levererar vi programvarulösningar till företag, organisationer och individer i praktiskt taget alla branscher som gör det möjligt för alla team, stora som små att arbeta effektivt och säkert i ett intuitivt och enkelt arbetsflöde. För mer information: www.hoylu.com Kortnamn: Hoylu Marknadsplats: Nasdaq First North Growth Market Certified Adviser: Mangold Fondkommission AB + 46 (0) 8 50 301 550, ca@mangold.se Publicering Denna information är sådan information som Hoylu AB (publ) är skyldig att offentliggöra enli

Hoylu AB: Publishes its Annual Report for 20192.6.2020 23:30:00 CESTPress release

Hoylu AB (publ) announced today that the Annual Report for 2019 is available at Hoylu’s web site: https://www.hoylu.com/investor-relations/financial-reports/ For more information, please contact: Stein Revelsby, CEO at Hoylu +1 213 440 2499 Email: sr@hoylu.com Karl Wiersholm, CFO at Hoylu +1 425 829 2316 Email: kw@hoylu.com About Hoylu Hoylu’s mission is to make remote work and information sharing easy. Through our customizable Connected Workspaces™ we deliver software solutions for companies, organizations and individuals across virtually all industries that enable all teams, big and small to work efficiently and securely in an intuitive and easy workflow. For more information: www.hoylu.com. Ticker symbol: Hoylu Marketplace: Nasdaq First North Growth Market Certified Adviser: Mangold Fondkommission AB +46 (0) 8 50 301 550, ca@mangold.se Publication This information is information that Hoylu AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was s

Novartis provides update on FDA review of ofatumumab, a self-administered, targeted B-cell therapy for patients with relapsing multiple sclerosis2.6.2020 22:05:00 CESTPress release

Basel, June 2, 2020 — Novartis today announced that it has received notice from the US Food and Drug Administration (FDA) that the agency has extended its review of the Supplemental Biologics License Application (sBLA) for ofatumumab (OMB 157), a self-administered, targeted B-cell therapy for patients with relapsing multiple sclerosis. Regulatory action is now expected in September 2020. “Novartis will continue to work with the FDA to complete the review as soon as possible,” said Marie-France Tschudin, President, Novartis Pharmaceuticals. “We are well prepared and ready to launch ofatumumab upon approval. We are committed to the MS community and look forward to bringing this important advancement to patients with MS.” Additional regulatory filings are currently underway and regulatory approval for ofatumumab in Europe is expected by Q2 2021. About ofatumumab Ofatumumab (OMB 157) is a fully human anti-CD20 monoclonal antibody (mAb) in development for RMS that is self-adminstered by a o